MELISSA PANTELIODIS: Open Payments
NPI 1770143729 · PINELLAS PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 37 payments from 9 companies in 2025. Trend: 2023 $1,387 · 2024 $1,336 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 9 | $152 |
| AstraZeneca Pharmaceuticals LP | 7 | $133 |
| GlaxoSmithKline, LLC. | 6 | $128 |
| Grifols USA, LLC | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| GENZYME CORPORATION | 2 | $57 |
| Genentech USA, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $21 |
Products named: DUPIXENT, Xembify, Hizentra, Andembry, TRELEGY ELLIPTA, NUCALA, BREZTRI, Xolair.
Industry payments across FL — which companies pay providers there.
